

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.97755586 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.97755586 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.53767743 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.53767743 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.04881450 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 5.23830476 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 5.23830476 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.23830476 |
| 9 | bile acid biosynthetic process (GO:0006699) | 5.15424059 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.09313214 |
| 11 | nerve growth factor signaling pathway (GO:0038180) | 5.02331000 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.01632497 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.97475059 |
| 14 | glyoxylate metabolic process (GO:0046487) | 4.93980486 |
| 15 | cysteine metabolic process (GO:0006534) | 4.89321012 |
| 16 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 4.86860147 |
| 17 | lysine metabolic process (GO:0006553) | 4.82457031 |
| 18 | lysine catabolic process (GO:0006554) | 4.82457031 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 4.71991652 |
| 20 | regulation of glucokinase activity (GO:0033131) | 4.66660857 |
| 21 | regulation of hexokinase activity (GO:1903299) | 4.66660857 |
| 22 | negative regulation of neurotransmitter transport (GO:0051589) | 4.65385500 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.53190010 |
| 24 | protein carboxylation (GO:0018214) | 4.52551089 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.52551089 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 4.46578953 |
| 27 | aromatic amino acid family metabolic process (GO:0009072) | 4.42824880 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.42674637 |
| 29 | urea metabolic process (GO:0019627) | 4.41872321 |
| 30 | urea cycle (GO:0000050) | 4.41872321 |
| 31 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.40367311 |
| 32 | tyrosine metabolic process (GO:0006570) | 4.38431764 |
| 33 | complement activation, alternative pathway (GO:0006957) | 4.37724847 |
| 34 | response to pheromone (GO:0019236) | 4.36899154 |
| 35 | regulation of fibrinolysis (GO:0051917) | 4.34685545 |
| 36 | negative regulation of fibrinolysis (GO:0051918) | 4.33335437 |
| 37 | bile acid metabolic process (GO:0008206) | 4.33008522 |
| 38 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.31797636 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 4.30829148 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.21621341 |
| 41 | coenzyme catabolic process (GO:0009109) | 4.19844046 |
| 42 | regulation of complement activation (GO:0030449) | 4.16436568 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 4.13192730 |
| 44 | glutamate metabolic process (GO:0006536) | 4.10455679 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 4.07617742 |
| 46 | homocysteine metabolic process (GO:0050667) | 4.05809362 |
| 47 | short-chain fatty acid metabolic process (GO:0046459) | 4.05517613 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.02829562 |
| 49 | aspartate family amino acid catabolic process (GO:0009068) | 3.98286405 |
| 50 | positive regulation of mitochondrial fission (GO:0090141) | 3.94459666 |
| 51 | cellular amino acid catabolic process (GO:0009063) | 3.94300162 |
| 52 | reverse cholesterol transport (GO:0043691) | 3.92371288 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 3.90119522 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 3.89697886 |
| 55 | triglyceride homeostasis (GO:0070328) | 3.89053727 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.89053727 |
| 57 | acetyl-CoA metabolic process (GO:0006084) | 3.85304661 |
| 58 | regulation of cholesterol esterification (GO:0010872) | 3.84018507 |
| 59 | protein-lipid complex remodeling (GO:0034368) | 3.82458149 |
| 60 | macromolecular complex remodeling (GO:0034367) | 3.82458149 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 3.82458149 |
| 62 | ethanol oxidation (GO:0006069) | 3.81481747 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.80166012 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 3.72698929 |
| 65 | amine catabolic process (GO:0009310) | 3.72698929 |
| 66 | ketone body metabolic process (GO:1902224) | 3.72264761 |
| 67 | cellular modified amino acid catabolic process (GO:0042219) | 3.69432151 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 3.64325393 |
| 69 | drug catabolic process (GO:0042737) | 3.63586696 |
| 70 | startle response (GO:0001964) | 3.63392617 |
| 71 | dopamine transport (GO:0015872) | 3.61603405 |
| 72 | cofactor catabolic process (GO:0051187) | 3.61046536 |
| 73 | bile acid and bile salt transport (GO:0015721) | 3.56042100 |
| 74 | organic acid catabolic process (GO:0016054) | 3.52624756 |
| 75 | carboxylic acid catabolic process (GO:0046395) | 3.52624756 |
| 76 | cellular glucuronidation (GO:0052695) | 3.51914357 |
| 77 | phospholipid efflux (GO:0033700) | 3.51892694 |
| 78 | cholesterol efflux (GO:0033344) | 3.50207271 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.48069075 |
| 80 | imidazole-containing compound metabolic process (GO:0052803) | 3.46960719 |
| 81 | aldehyde catabolic process (GO:0046185) | 3.46511387 |
| 82 | neural tube formation (GO:0001841) | 3.44915924 |
| 83 | drug transmembrane transport (GO:0006855) | 3.44549031 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 3.43044510 |
| 85 | fatty acid oxidation (GO:0019395) | 3.42205265 |
| 86 | monocarboxylic acid catabolic process (GO:0072329) | 3.41410309 |
| 87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.37667168 |
| 88 | fatty acid catabolic process (GO:0009062) | 3.36954583 |
| 89 | 2-oxoglutarate metabolic process (GO:0006103) | 3.36792159 |
| 90 | lipid oxidation (GO:0034440) | 3.36252106 |
| 91 | positive regulation of vasculogenesis (GO:2001214) | 3.35958939 |
| 92 | protein localization to cilium (GO:0061512) | 3.35780954 |
| 93 | negative regulation of sterol transport (GO:0032372) | 3.35414130 |
| 94 | negative regulation of cholesterol transport (GO:0032375) | 3.35414130 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.34856640 |
| 96 | establishment of protein localization to Golgi (GO:0072600) | 3.30551829 |
| 97 | arginine metabolic process (GO:0006525) | 3.28795227 |
| 98 | nonmotile primary cilium assembly (GO:0035058) | 3.28530841 |
| 99 | fibrinolysis (GO:0042730) | 3.28367228 |
| 100 | exogenous drug catabolic process (GO:0042738) | 3.24208281 |
| 101 | heme transport (GO:0015886) | 3.21146711 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.18107748 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.18107748 |
| 104 | negative regulation of lipase activity (GO:0060192) | 3.17797746 |
| 105 | presynaptic membrane assembly (GO:0097105) | 3.17758899 |
| 106 | very long-chain fatty acid metabolic process (GO:0000038) | 3.17636587 |
| 107 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.16706443 |
| 108 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.16608254 |
| 109 | opsonization (GO:0008228) | 3.15915588 |
| 110 | urate metabolic process (GO:0046415) | 3.15753288 |
| 111 | branched-chain amino acid catabolic process (GO:0009083) | 3.13672078 |
| 112 | low-density lipoprotein particle remodeling (GO:0034374) | 3.13089474 |
| 113 | protein targeting to Golgi (GO:0000042) | 3.12392953 |
| 114 | cytolysis (GO:0019835) | 3.12340450 |
| 115 | glycine metabolic process (GO:0006544) | 3.11574429 |
| 116 | blood coagulation, intrinsic pathway (GO:0007597) | 3.11138045 |
| 117 | regulation of synaptic vesicle transport (GO:1902803) | 3.10998782 |
| 118 | plasma lipoprotein particle assembly (GO:0034377) | 3.10988618 |
| 119 | regulation of cholesterol metabolic process (GO:0090181) | 3.10649099 |
| 120 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.02698001 |
| 121 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.99882945 |
| 122 | protein prenylation (GO:0018342) | 2.99264092 |
| 123 | prenylation (GO:0097354) | 2.99264092 |
| 124 | intraciliary transport (GO:0042073) | 2.89283915 |
| 125 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.86206712 |
| 126 | presynaptic membrane organization (GO:0097090) | 2.85654385 |
| 127 | cilium morphogenesis (GO:0060271) | 2.83966467 |
| 128 | platelet dense granule organization (GO:0060155) | 2.80761006 |
| 129 | C4-dicarboxylate transport (GO:0015740) | 2.73952002 |
| 130 | nucleobase catabolic process (GO:0046113) | 2.72980525 |
| 131 | cilium assembly (GO:0042384) | 2.72310239 |
| 132 | cilium organization (GO:0044782) | 2.71050819 |
| 133 | photoreceptor cell maintenance (GO:0045494) | 2.67953284 |
| 134 | neuronal action potential propagation (GO:0019227) | 2.67076173 |
| 135 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.66526410 |
| 136 | epithelial cilium movement (GO:0003351) | 2.66294437 |
| 137 | axoneme assembly (GO:0035082) | 2.66042907 |
| 138 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.66019016 |
| 139 | regulation of mitochondrial fission (GO:0090140) | 2.65749471 |
| 140 | rRNA methylation (GO:0031167) | 2.65575436 |
| 141 | inner ear receptor stereocilium organization (GO:0060122) | 2.65479370 |
| 142 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.62226571 |
| 143 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.62226571 |
| 144 | postsynaptic membrane organization (GO:0001941) | 2.61477675 |
| 145 | auditory receptor cell stereocilium organization (GO:0060088) | 2.60081121 |
| 146 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.59579398 |
| 147 | regulation of establishment of cell polarity (GO:2000114) | 2.56581923 |
| 148 | righting reflex (GO:0060013) | 2.56312662 |
| 149 | reflex (GO:0060004) | 2.55481145 |
| 150 | inositol phosphate catabolic process (GO:0071545) | 2.55382729 |
| 151 | glycosphingolipid biosynthetic process (GO:0006688) | 2.55107944 |
| 152 | positive regulation of glycolytic process (GO:0045821) | 2.53828797 |
| 153 | protein K6-linked ubiquitination (GO:0085020) | 2.53078266 |
| 154 | L-fucose catabolic process (GO:0042355) | 2.52947289 |
| 155 | fucose catabolic process (GO:0019317) | 2.52947289 |
| 156 | L-fucose metabolic process (GO:0042354) | 2.52947289 |
| 157 | regulation of cell communication by electrical coupling (GO:0010649) | 2.52466908 |
| 158 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.51540459 |
| 159 | regulation of sarcomere organization (GO:0060297) | 2.51508963 |
| 160 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.50664624 |
| 161 | neuron cell-cell adhesion (GO:0007158) | 2.48915914 |
| 162 | regulation of relaxation of muscle (GO:1901077) | 2.48599605 |
| 163 | regulation of vasculogenesis (GO:2001212) | 2.48578011 |
| 164 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.46710187 |
| 165 | neurotransmitter uptake (GO:0001504) | 2.46285141 |
| 166 | protein localization to Golgi apparatus (GO:0034067) | 2.45616635 |
| 167 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.45483248 |
| 168 | anterograde synaptic vesicle transport (GO:0048490) | 2.43922361 |
| 169 | inositol metabolic process (GO:0006020) | 2.42074007 |
| 170 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.41286099 |
| 171 | auditory behavior (GO:0031223) | 2.37986683 |
| 172 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.37373827 |
| 173 | polyol catabolic process (GO:0046174) | 2.36573930 |
| 174 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.35903181 |
| 175 | gamma-aminobutyric acid transport (GO:0015812) | 2.34333517 |
| 176 | protein K11-linked deubiquitination (GO:0035871) | 2.32435398 |
| 177 | relaxation of smooth muscle (GO:0044557) | 2.32262430 |
| 178 | Rap protein signal transduction (GO:0032486) | 2.32034089 |
| 179 | synaptic transmission, glutamatergic (GO:0035249) | 2.31286290 |
| 180 | acrosome assembly (GO:0001675) | 2.31280305 |
| 181 | calcium ion import (GO:0070509) | 2.29836082 |
| 182 | catecholamine transport (GO:0051937) | 2.29612181 |
| 183 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.29284703 |
| 184 | microtubule anchoring (GO:0034453) | 2.29002695 |
| 185 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.28748236 |
| 186 | inositol phosphate dephosphorylation (GO:0046855) | 2.28748236 |
| 187 | regulation of respiratory system process (GO:0044065) | 2.28720688 |
| 188 | regulation of male gonad development (GO:2000018) | 2.26957744 |
| 189 | regulation of neurotransmitter transport (GO:0051588) | 2.25784766 |
| 190 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.25556028 |
| 191 | DNA double-strand break processing (GO:0000729) | 2.25370518 |
| 192 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.25153977 |
| 193 | detection of light stimulus involved in visual perception (GO:0050908) | 2.25153977 |
| 194 | synapse assembly (GO:0007416) | 2.24911630 |
| 195 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.24805808 |
| 196 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.24596112 |
| 197 | positive regulation of male gonad development (GO:2000020) | 2.24025404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.90948201 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.23319048 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.16838095 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.06461253 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.97680992 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.06355981 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.58346166 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.58151842 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.36607223 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.24302536 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.74849991 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.64260158 |
| 13 | FUS_26573619_Chip-Seq_HEK293_Human | 2.38922303 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.28678058 |
| 15 | EWS_26573619_Chip-Seq_HEK293_Human | 2.22967611 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.17390424 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.06913626 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.95769737 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.94323400 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.82332152 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.75113350 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.71815269 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67189408 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.64192107 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60599523 |
| 26 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.55380272 |
| 27 | TCF4_23295773_ChIP-Seq_U87_Human | 1.55321940 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.49170409 |
| 29 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.48542047 |
| 30 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.45976742 |
| 31 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45645141 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.42817511 |
| 33 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.37425015 |
| 34 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.37290775 |
| 35 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.37209134 |
| 36 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36797228 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.36379035 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.36379035 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32259525 |
| 40 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.31715102 |
| 41 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.31338302 |
| 42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.31313771 |
| 43 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.30684423 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.29627988 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29314212 |
| 46 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.27674773 |
| 47 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.25967475 |
| 48 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24938930 |
| 49 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.23786369 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22445710 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21679578 |
| 52 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21092216 |
| 53 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20996643 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20084968 |
| 55 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17248658 |
| 56 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16708898 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15937340 |
| 58 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.15778758 |
| 59 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.15359841 |
| 60 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15359841 |
| 61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12780648 |
| 62 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.11490600 |
| 63 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10946025 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09503145 |
| 65 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08635660 |
| 66 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.08520618 |
| 67 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08456546 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06864739 |
| 69 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06531158 |
| 70 | JUN_21703547_ChIP-Seq_K562_Human | 1.06385013 |
| 71 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05640983 |
| 72 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.04481008 |
| 73 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04340505 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04148000 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03587594 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03517020 |
| 77 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.03201515 |
| 78 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.03035018 |
| 79 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02635563 |
| 80 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02315062 |
| 81 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.02171691 |
| 82 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02064460 |
| 83 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.01203691 |
| 84 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01135634 |
| 85 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00669519 |
| 86 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.99267520 |
| 87 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98958871 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94707438 |
| 89 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.94584973 |
| 90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92989367 |
| 91 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92206781 |
| 92 | P300_19829295_ChIP-Seq_ESCs_Human | 0.91998904 |
| 93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.91555848 |
| 94 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89011753 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88881457 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88729259 |
| 97 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88580162 |
| 98 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.88080357 |
| 99 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87694240 |
| 100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86063938 |
| 101 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85786377 |
| 102 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.85638689 |
| 103 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.83538300 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83215773 |
| 105 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82593096 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81365989 |
| 107 | CBP_21632823_ChIP-Seq_H3396_Human | 0.79951900 |
| 108 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79674409 |
| 109 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.78867654 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.78669364 |
| 111 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.78631146 |
| 112 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77508227 |
| 113 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.77168613 |
| 114 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.77154128 |
| 115 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.76859620 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76516114 |
| 117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.75607651 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.75265106 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.75265106 |
| 120 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.74807356 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74554902 |
| 122 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.73998900 |
| 123 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.73807388 |
| 124 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.73759507 |
| 125 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.72790112 |
| 126 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.72790112 |
| 127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71632533 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.71316000 |
| 129 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.71062486 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.70270867 |
| 131 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.70015776 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.69447320 |
| 133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.68986675 |
| 134 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.68790121 |
| 135 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.68179558 |
| 136 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.66815109 |
| 137 | NCOR_22424771_ChIP-Seq_293T_Human | 0.66434299 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66259022 |
| 139 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.66120959 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.65498260 |
| 141 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.65251656 |
| 142 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.65143246 |
| 143 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.64827334 |
| 144 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.64748974 |
| 145 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64636635 |
| 146 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64543627 |
| 147 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.64330753 |
| 148 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.63881208 |
| 149 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.62981740 |
| 150 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.62893331 |
| 151 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.62758967 |
| 152 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.62669127 |
| 153 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.62669127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.48690504 |
| 2 | MP0005360_urolithiasis | 6.47186319 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.64490862 |
| 4 | MP0005365_abnormal_bile_salt | 5.17677132 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.42357740 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.15330163 |
| 7 | MP0003195_calcinosis | 3.42865733 |
| 8 | MP0003252_abnormal_bile_duct | 3.33716359 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.92189695 |
| 10 | MP0005083_abnormal_biliary_tract | 2.80679693 |
| 11 | MP0005332_abnormal_amino_acid | 2.66958365 |
| 12 | MP0002102_abnormal_ear_morphology | 2.36809166 |
| 13 | MP0009840_abnormal_foam_cell | 2.34253008 |
| 14 | MP0001984_abnormal_olfaction | 2.27591007 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.23694387 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.22016609 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 1.99695975 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.96890929 |
| 19 | MP0008877_abnormal_DNA_methylation | 1.96213841 |
| 20 | MP0004084_abnormal_cardiac_muscle | 1.92851118 |
| 21 | MP0006072_abnormal_retinal_apoptosis | 1.91343151 |
| 22 | MP0001529_abnormal_vocalization | 1.89828972 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.88775269 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.80584991 |
| 25 | MP0005253_abnormal_eye_physiology | 1.80442617 |
| 26 | MP0003122_maternal_imprinting | 1.78857529 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.77427535 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.73375327 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.70822758 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.69916164 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.67733358 |
| 32 | MP0000609_abnormal_liver_physiology | 1.66985786 |
| 33 | MP0003868_abnormal_feces_composition | 1.61573735 |
| 34 | MP0003635_abnormal_synaptic_transmissio | 1.60730890 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58381152 |
| 36 | MP0004885_abnormal_endolymph | 1.56778262 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.55585090 |
| 38 | MP0003787_abnormal_imprinting | 1.51806368 |
| 39 | MP0001764_abnormal_homeostasis | 1.51393150 |
| 40 | MP0009697_abnormal_copulation | 1.47648159 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.45969091 |
| 42 | MP0002822_catalepsy | 1.45855789 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 1.45309863 |
| 44 | MP0004924_abnormal_behavior | 1.41875517 |
| 45 | MP0005386_behavior/neurological_phenoty | 1.41875517 |
| 46 | MP0005187_abnormal_penis_morphology | 1.40218584 |
| 47 | MP0002734_abnormal_mechanical_nocicepti | 1.39649106 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.38920413 |
| 49 | MP0004147_increased_porphyrin_level | 1.35718851 |
| 50 | MP0004043_abnormal_pH_regulation | 1.35071276 |
| 51 | MP0003121_genomic_imprinting | 1.34365826 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.34222001 |
| 53 | MP0000778_abnormal_nervous_system | 1.34062255 |
| 54 | MP0000751_myopathy | 1.33307714 |
| 55 | MP0004133_heterotaxia | 1.28519542 |
| 56 | MP0002063_abnormal_learning/memory/cond | 1.25451532 |
| 57 | MP0002234_abnormal_pharynx_morphology | 1.24925650 |
| 58 | MP0003690_abnormal_glial_cell | 1.23924011 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.20128367 |
| 60 | MP0008057_abnormal_DNA_replication | 1.20083824 |
| 61 | MP0005379_endocrine/exocrine_gland_phen | 1.19874722 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.18980294 |
| 63 | MP0005535_abnormal_body_temperature | 1.18831040 |
| 64 | MP0004130_abnormal_muscle_cell | 1.18802908 |
| 65 | MP0003329_amyloid_beta_deposits | 1.18780397 |
| 66 | MP0005670_abnormal_white_adipose | 1.18705229 |
| 67 | MP0008058_abnormal_DNA_repair | 1.18062706 |
| 68 | MP0004484_altered_response_of | 1.16471327 |
| 69 | MP0002876_abnormal_thyroid_physiology | 1.16285178 |
| 70 | MP0000604_amyloidosis | 1.16056268 |
| 71 | MP0002067_abnormal_sensory_capabilities | 1.15771125 |
| 72 | MP0008789_abnormal_olfactory_epithelium | 1.15354794 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 1.13619516 |
| 74 | MP0005423_abnormal_somatic_nervous | 1.12606089 |
| 75 | MP0005620_abnormal_muscle_contractility | 1.11853766 |
| 76 | MP0001188_hyperpigmentation | 1.11331778 |
| 77 | MP0005451_abnormal_body_composition | 1.10803495 |
| 78 | MP0002095_abnormal_skin_pigmentation | 1.07143600 |
| 79 | MP0000427_abnormal_hair_cycle | 1.06827309 |
| 80 | MP0001970_abnormal_pain_threshold | 1.05165698 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 1.04040281 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 1.03109887 |
| 83 | MP0003186_abnormal_redox_activity | 1.02940817 |
| 84 | MP0001905_abnormal_dopamine_level | 0.99858853 |
| 85 | MP0002184_abnormal_innervation | 0.99354356 |
| 86 | MP0005248_abnormal_Harderian_gland | 0.96619415 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.95204075 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.94220892 |
| 89 | MP0003136_yellow_coat_color | 0.93391549 |
| 90 | MP0002106_abnormal_muscle_physiology | 0.92828909 |
| 91 | MP0002557_abnormal_social/conspecific_i | 0.92704776 |
| 92 | MP0004811_abnormal_neuron_physiology | 0.91716241 |
| 93 | MP0002733_abnormal_thermal_nociception | 0.91636384 |
| 94 | MP0004270_analgesia | 0.91427496 |
| 95 | MP0002971_abnormal_brown_adipose | 0.90339792 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.88956382 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 0.88703339 |
| 98 | MP0002751_abnormal_autonomic_nervous | 0.88093412 |
| 99 | MP0004085_abnormal_heartbeat | 0.87789050 |
| 100 | MP0000955_abnormal_spinal_cord | 0.86666100 |
| 101 | MP0000013_abnormal_adipose_tissue | 0.86330659 |
| 102 | MP0001661_extended_life_span | 0.86179835 |
| 103 | MP0008775_abnormal_heart_ventricle | 0.86042561 |
| 104 | MP0002882_abnormal_neuron_morphology | 0.84738500 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.84221469 |
| 106 | MP0005499_abnormal_olfactory_system | 0.84221469 |
| 107 | MP0009780_abnormal_chondrocyte_physiolo | 0.83556122 |
| 108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83395248 |
| 109 | MP0002127_abnormal_cardiovascular_syste | 0.83012648 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.82461332 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.82032932 |
| 112 | MP0000920_abnormal_myelination | 0.81246482 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.81194245 |
| 114 | MP0002332_abnormal_exercise_endurance | 0.80906310 |
| 115 | MP0005171_absent_coat_pigmentation | 0.80618329 |
| 116 | MP0005647_abnormal_sex_gland | 0.80532101 |
| 117 | MP0009764_decreased_sensitivity_to | 0.80358883 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.79942241 |
| 119 | MP0004142_abnormal_muscle_tone | 0.79743958 |
| 120 | MP0002269_muscular_atrophy | 0.79041110 |
| 121 | MP0000747_muscle_weakness | 0.77746130 |
| 122 | MP0005334_abnormal_fat_pad | 0.76537539 |
| 123 | MP0002735_abnormal_chemical_nociception | 0.75751820 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.74945343 |
| 125 | MP0004036_abnormal_muscle_relaxation | 0.74852053 |
| 126 | MP0000749_muscle_degeneration | 0.73469301 |
| 127 | MP0009642_abnormal_blood_homeostasis | 0.73261072 |
| 128 | MP0003880_abnormal_central_pattern | 0.72880590 |
| 129 | MP0000598_abnormal_liver_morphology | 0.72527817 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.72433632 |
| 131 | MP0005266_abnormal_metabolism | 0.70336049 |
| 132 | MP0003183_abnormal_peptide_metabolism | 0.69100927 |
| 133 | MP0002272_abnormal_nervous_system | 0.68355252 |
| 134 | MP0003011_delayed_dark_adaptation | 0.68111235 |
| 135 | MP0004859_abnormal_synaptic_plasticity | 0.67696726 |
| 136 | MP0004145_abnormal_muscle_electrophysio | 0.66948072 |
| 137 | MP0002064_seizures | 0.66040593 |
| 138 | MP0005408_hypopigmentation | 0.65664910 |
| 139 | MP0001765_abnormal_ion_homeostasis | 0.64482278 |
| 140 | MP0005448_abnormal_energy_balance | 0.64156017 |
| 141 | MP0008874_decreased_physiological_sensi | 0.62694210 |
| 142 | MP0001756_abnormal_urination | 0.62593158 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.62579040 |
| 144 | MP0009745_abnormal_behavioral_response | 0.62509098 |
| 145 | MP0002229_neurodegeneration | 0.60520926 |
| 146 | MP0006276_abnormal_autonomic_nervous | 0.60375438 |
| 147 | MP0009763_increased_sensitivity_to | 0.60145853 |
| 148 | MP0004215_abnormal_myocardial_fiber | 0.58764285 |
| 149 | MP0003633_abnormal_nervous_system | 0.58725465 |
| 150 | MP0001440_abnormal_grooming_behavior | 0.57983896 |
| 151 | MP0005058_abnormal_lysosome_morphology | 0.57079069 |
| 152 | MP0005220_abnormal_exocrine_pancreas | 0.56072149 |
| 153 | MP0009384_cardiac_valve_regurgitation | 0.56054070 |
| 154 | MP0003953_abnormal_hormone_level | 0.55172106 |
| 155 | MP0005330_cardiomyopathy | 0.54961210 |
| 156 | MP0000639_abnormal_adrenal_gland | 0.54309682 |
| 157 | MP0002736_abnormal_nociception_after | 0.53186909 |
| 158 | MP0003646_muscle_fatigue | 0.52263701 |
| 159 | MP0001486_abnormal_startle_reflex | 0.51262581 |
| 160 | MP0008872_abnormal_physiological_respon | 0.50637624 |
| 161 | MP0008260_abnormal_autophagy | 0.50458801 |
| 162 | MP0003631_nervous_system_phenotype | 0.50136585 |
| 163 | MP0002090_abnormal_vision | 0.49959736 |
| 164 | MP0001968_abnormal_touch/_nociception | 0.49601694 |
| 165 | MP0008469_abnormal_protein_level | 0.49583168 |
| 166 | MP0009046_muscle_twitch | 0.49360035 |
| 167 | MP0003075_altered_response_to | 0.49322638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.23784951 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.01058188 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.69908139 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.49305515 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.11873829 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.05024043 |
| 7 | Xanthomatosis (HP:0000991) | 5.04283258 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.53681615 |
| 9 | Ketosis (HP:0001946) | 4.26727109 |
| 10 | Complement deficiency (HP:0004431) | 4.22541916 |
| 11 | Hyperglycinemia (HP:0002154) | 4.20411970 |
| 12 | Hyperammonemia (HP:0001987) | 4.03485973 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.01977239 |
| 14 | Hypolipoproteinemia (HP:0010981) | 3.85780719 |
| 15 | Medial flaring of the eyebrow (HP:0010747) | 3.76928006 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.73126604 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.73126604 |
| 18 | Hyperglycinuria (HP:0003108) | 3.65864636 |
| 19 | Ketoacidosis (HP:0001993) | 3.64776992 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.63738246 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 3.58858999 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.56165221 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 3.55900697 |
| 24 | Joint hemorrhage (HP:0005261) | 3.55568961 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.52811285 |
| 26 | Fat malabsorption (HP:0002630) | 3.48109895 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.42751779 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.40391894 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.36431879 |
| 30 | Gait imbalance (HP:0002141) | 3.36153460 |
| 31 | Epidermoid cyst (HP:0200040) | 3.33016677 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.31215078 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27983489 |
| 34 | Congenital primary aphakia (HP:0007707) | 3.25893156 |
| 35 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.25323331 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.25142494 |
| 37 | Febrile seizures (HP:0002373) | 3.22743052 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.11209201 |
| 39 | Pancreatic cysts (HP:0001737) | 3.01718173 |
| 40 | Nephrogenic diabetes insipidus (HP:0009806) | 3.01172938 |
| 41 | Nephronophthisis (HP:0000090) | 3.00913891 |
| 42 | Gout (HP:0001997) | 2.98037819 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.97357783 |
| 44 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.94560875 |
| 45 | Gaze-evoked nystagmus (HP:0000640) | 2.93583250 |
| 46 | Pancreatic fibrosis (HP:0100732) | 2.93431376 |
| 47 | True hermaphroditism (HP:0010459) | 2.92953621 |
| 48 | Genetic anticipation (HP:0003743) | 2.92231683 |
| 49 | Absent speech (HP:0001344) | 2.88547998 |
| 50 | Metabolic acidosis (HP:0001942) | 2.87979083 |
| 51 | Abnormality of complement system (HP:0005339) | 2.86397737 |
| 52 | Abnormal gallbladder morphology (HP:0012437) | 2.86074193 |
| 53 | Cerebral edema (HP:0002181) | 2.85156943 |
| 54 | Molar tooth sign on MRI (HP:0002419) | 2.81975023 |
| 55 | Abnormality of midbrain morphology (HP:0002418) | 2.81975023 |
| 56 | Hypoglycemic seizures (HP:0002173) | 2.81658191 |
| 57 | Cholelithiasis (HP:0001081) | 2.79413172 |
| 58 | Lethargy (HP:0001254) | 2.72507429 |
| 59 | Steatorrhea (HP:0002570) | 2.70788688 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.69596936 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.69596936 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.66944789 |
| 63 | Genital tract atresia (HP:0001827) | 2.65426141 |
| 64 | Drooling (HP:0002307) | 2.60683754 |
| 65 | Abnormality of the renal cortex (HP:0011035) | 2.59051783 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.57775285 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.56065058 |
| 68 | Abnormality of the renal medulla (HP:0100957) | 2.55627729 |
| 69 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53627322 |
| 70 | Calf muscle hypertrophy (HP:0008981) | 2.50991809 |
| 71 | Vaginal atresia (HP:0000148) | 2.50304442 |
| 72 | Amyotrophic lateral sclerosis (HP:0007354) | 2.49634539 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 2.49534741 |
| 74 | Cholecystitis (HP:0001082) | 2.49534741 |
| 75 | Skin nodule (HP:0200036) | 2.48054150 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.47591618 |
| 77 | Muscle fiber inclusion bodies (HP:0100299) | 2.47220298 |
| 78 | Progressive cerebellar ataxia (HP:0002073) | 2.46794163 |
| 79 | Chronic hepatic failure (HP:0100626) | 2.45974202 |
| 80 | Renal cortical cysts (HP:0000803) | 2.45419441 |
| 81 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.45331396 |
| 82 | Nemaline bodies (HP:0003798) | 2.43105219 |
| 83 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.41664905 |
| 84 | Hypochromic microcytic anemia (HP:0004840) | 2.40384355 |
| 85 | Hypoplasia of the fovea (HP:0007750) | 2.39679100 |
| 86 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.39679100 |
| 87 | Broad-based gait (HP:0002136) | 2.37928704 |
| 88 | Rimmed vacuoles (HP:0003805) | 2.36651002 |
| 89 | Pheochromocytoma (HP:0002666) | 2.35412716 |
| 90 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.33218003 |
| 91 | Vascular calcification (HP:0004934) | 2.31611678 |
| 92 | Thyroiditis (HP:0100646) | 2.30342750 |
| 93 | Progressive inability to walk (HP:0002505) | 2.30282803 |
| 94 | Excessive salivation (HP:0003781) | 2.28543430 |
| 95 | Hepatocellular carcinoma (HP:0001402) | 2.27616493 |
| 96 | Polyphagia (HP:0002591) | 2.26570585 |
| 97 | Hemiparesis (HP:0001269) | 2.25786343 |
| 98 | Irritability (HP:0000737) | 2.24748566 |
| 99 | Focal motor seizures (HP:0011153) | 2.23391693 |
| 100 | Myoglobinuria (HP:0002913) | 2.23258705 |
| 101 | Vomiting (HP:0002013) | 2.22881817 |
| 102 | Acanthocytosis (HP:0001927) | 2.22473726 |
| 103 | Volvulus (HP:0002580) | 2.21945814 |
| 104 | Poor coordination (HP:0002370) | 2.20771687 |
| 105 | Abnormality of the fovea (HP:0000493) | 2.20089803 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 2.19385870 |
| 107 | Tubulointerstitial nephritis (HP:0001970) | 2.19226959 |
| 108 | Exercise-induced myalgia (HP:0003738) | 2.18646108 |
| 109 | Abnormality of the gallbladder (HP:0005264) | 2.18308714 |
| 110 | Abnormality of glycolysis (HP:0004366) | 2.17516864 |
| 111 | Increased serum pyruvate (HP:0003542) | 2.17516864 |
| 112 | Late onset (HP:0003584) | 2.17378315 |
| 113 | Spontaneous abortion (HP:0005268) | 2.15326780 |
| 114 | Acute encephalopathy (HP:0006846) | 2.14991439 |
| 115 | Brushfield spots (HP:0001088) | 2.13985990 |
| 116 | Symptomatic seizures (HP:0011145) | 2.12782943 |
| 117 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.12279801 |
| 118 | Hypothermia (HP:0002045) | 2.11595451 |
| 119 | Inability to walk (HP:0002540) | 2.09333983 |
| 120 | Hyperventilation (HP:0002883) | 2.07319778 |
| 121 | Intestinal atresia (HP:0011100) | 2.07172841 |
| 122 | Neonatal onset (HP:0003623) | 2.05987900 |
| 123 | Cardiovascular calcification (HP:0011915) | 2.04678083 |
| 124 | Abnormality of the calf musculature (HP:0001430) | 2.04619015 |
| 125 | Congenital hepatic fibrosis (HP:0002612) | 2.04200637 |
| 126 | Anterior segment dysgenesis (HP:0007700) | 2.03016531 |
| 127 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.02308688 |
| 128 | Abnormality of alanine metabolism (HP:0010916) | 2.02308688 |
| 129 | Hyperalaninemia (HP:0003348) | 2.02308688 |
| 130 | Neuroendocrine neoplasm (HP:0100634) | 2.01706188 |
| 131 | Abnormality of vitamin metabolism (HP:0100508) | 2.01576290 |
| 132 | Postaxial foot polydactyly (HP:0001830) | 1.99732639 |
| 133 | Status epilepticus (HP:0002133) | 1.99516602 |
| 134 | Papillary thyroid carcinoma (HP:0002895) | 1.99212308 |
| 135 | Hypoproteinemia (HP:0003075) | 1.97324508 |
| 136 | Mitral stenosis (HP:0001718) | 1.96466856 |
| 137 | Spastic paraparesis (HP:0002313) | 1.95083886 |
| 138 | Left ventricular hypertrophy (HP:0001712) | 1.94136411 |
| 139 | Fair hair (HP:0002286) | 1.93078903 |
| 140 | Hyperglycemia (HP:0003074) | 1.92930558 |
| 141 | Proximal tubulopathy (HP:0000114) | 1.92868014 |
| 142 | Poikilocytosis (HP:0004447) | 1.92734065 |
| 143 | Increased purine levels (HP:0004368) | 1.91824421 |
| 144 | Hyperuricemia (HP:0002149) | 1.91824421 |
| 145 | Rickets (HP:0002748) | 1.91687082 |
| 146 | Opisthotonus (HP:0002179) | 1.90899026 |
| 147 | Postaxial hand polydactyly (HP:0001162) | 1.89005516 |
| 148 | Methylmalonic acidemia (HP:0002912) | 1.88948497 |
| 149 | Glomerulonephritis (HP:0000099) | 1.88703811 |
| 150 | Hepatic necrosis (HP:0002605) | 1.88545202 |
| 151 | Widely spaced teeth (HP:0000687) | 1.87853703 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.87672808 |
| 153 | Glycosuria (HP:0003076) | 1.87672808 |
| 154 | Short foot (HP:0001773) | 1.86965539 |
| 155 | Systemic lupus erythematosus (HP:0002725) | 1.86385866 |
| 156 | Alkalosis (HP:0001948) | 1.85966657 |
| 157 | Hypophosphatemic rickets (HP:0004912) | 1.85707971 |
| 158 | Myocardial infarction (HP:0001658) | 1.85579980 |
| 159 | Malnutrition (HP:0004395) | 1.83881983 |
| 160 | Cerebral hemorrhage (HP:0001342) | 1.80776010 |
| 161 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.80179564 |
| 162 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.79889385 |
| 163 | Subaortic stenosis (HP:0001682) | 1.79889385 |
| 164 | 3-Methylglutaconic aciduria (HP:0003535) | 1.79721520 |
| 165 | Attenuation of retinal blood vessels (HP:0007843) | 1.79656833 |
| 166 | Acute hepatic failure (HP:0006554) | 1.79536256 |
| 167 | Reticulocytosis (HP:0001923) | 1.79376406 |
| 168 | EEG with generalized epileptiform discharges (HP:0011198) | 1.79175102 |
| 169 | Pancreatitis (HP:0001733) | 1.77818641 |
| 170 | Specific learning disability (HP:0001328) | 1.77496839 |
| 171 | Congenital stationary night blindness (HP:0007642) | 1.75784626 |
| 172 | Abnormal drinking behavior (HP:0030082) | 1.75246895 |
| 173 | Polydipsia (HP:0001959) | 1.75246895 |
| 174 | Focal seizures (HP:0007359) | 1.74069634 |
| 175 | Epileptiform EEG discharges (HP:0011182) | 1.74050140 |
| 176 | Cerebellar dysplasia (HP:0007033) | 1.73623529 |
| 177 | Hypsarrhythmia (HP:0002521) | 1.72722617 |
| 178 | Long clavicles (HP:0000890) | 1.72389670 |
| 179 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.72139031 |
| 180 | Broad foot (HP:0001769) | 1.71276182 |
| 181 | Hip dysplasia (HP:0001385) | 1.70686293 |
| 182 | Large for gestational age (HP:0001520) | 1.67933622 |
| 183 | Agitation (HP:0000713) | 1.67497467 |
| 184 | Decreased testicular size (HP:0008734) | 1.65528248 |
| 185 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.65132140 |
| 186 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.65132140 |
| 187 | Thyroid carcinoma (HP:0002890) | 1.64948253 |
| 188 | Atonic seizures (HP:0010819) | 1.64863603 |
| 189 | Albinism (HP:0001022) | 1.64733949 |
| 190 | Dyskinesia (HP:0100660) | 1.64489404 |
| 191 | Cystic liver disease (HP:0006706) | 1.63666182 |
| 192 | Type II lissencephaly (HP:0007260) | 1.62472530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.98834312 |
| 2 | INSRR | 3.43046447 |
| 3 | MAP2K4 | 3.07998100 |
| 4 | MARK1 | 2.63931396 |
| 5 | TAOK3 | 2.55286568 |
| 6 | STK39 | 2.54613681 |
| 7 | PIK3CG | 2.54577762 |
| 8 | OXSR1 | 2.53692862 |
| 9 | SIK1 | 2.51718668 |
| 10 | TRIM28 | 2.37951815 |
| 11 | PINK1 | 2.28092550 |
| 12 | ERBB3 | 2.25043794 |
| 13 | BMPR1B | 2.21623839 |
| 14 | ERBB4 | 2.18059954 |
| 15 | WNK4 | 2.07319371 |
| 16 | EPHA4 | 1.92798773 |
| 17 | MAPK13 | 1.87218226 |
| 18 | MAP4K2 | 1.75508933 |
| 19 | OBSCN | 1.72101443 |
| 20 | PHKG2 | 1.63750825 |
| 21 | PHKG1 | 1.63750825 |
| 22 | DAPK2 | 1.62965399 |
| 23 | FGFR4 | 1.62585805 |
| 24 | NTRK3 | 1.61700897 |
| 25 | PLK2 | 1.59957288 |
| 26 | MAP3K4 | 1.50211178 |
| 27 | ERN1 | 1.49537167 |
| 28 | CASK | 1.44737005 |
| 29 | ACVR1B | 1.43043527 |
| 30 | NUAK1 | 1.41008343 |
| 31 | SGK223 | 1.34910324 |
| 32 | SGK494 | 1.34910324 |
| 33 | MET | 1.28620381 |
| 34 | PDK4 | 1.27851322 |
| 35 | PDK3 | 1.27851322 |
| 36 | NTRK1 | 1.25437295 |
| 37 | MAP3K7 | 1.23223016 |
| 38 | MAP3K12 | 1.22979605 |
| 39 | MAP3K13 | 1.21479343 |
| 40 | CAMK2G | 1.18966849 |
| 41 | MAP2K7 | 1.18820017 |
| 42 | AKT3 | 1.17093160 |
| 43 | KSR1 | 1.14012005 |
| 44 | EPHB1 | 1.12565094 |
| 45 | KSR2 | 1.12470291 |
| 46 | NEK9 | 1.10948604 |
| 47 | ADRBK2 | 1.08392293 |
| 48 | CSNK1A1L | 1.05939147 |
| 49 | ARAF | 1.04504044 |
| 50 | MAPK11 | 1.04238311 |
| 51 | FRK | 1.03604851 |
| 52 | PRKAA2 | 1.03558995 |
| 53 | TXK | 1.03453751 |
| 54 | MAP3K2 | 1.01847602 |
| 55 | PAK3 | 1.01374514 |
| 56 | MST1R | 0.99708762 |
| 57 | BCR | 0.98793553 |
| 58 | EIF2AK3 | 0.95078895 |
| 59 | WNK3 | 0.94419000 |
| 60 | SGK2 | 0.94045737 |
| 61 | PRKCG | 0.92266389 |
| 62 | GRK5 | 0.91987161 |
| 63 | PIK3CA | 0.89897454 |
| 64 | CAMK2A | 0.89877587 |
| 65 | MAPK12 | 0.89712308 |
| 66 | WNK1 | 0.88892562 |
| 67 | PAK6 | 0.88473477 |
| 68 | MKNK2 | 0.87443188 |
| 69 | FGFR2 | 0.87114506 |
| 70 | PDK2 | 0.87039260 |
| 71 | PDPK1 | 0.85463016 |
| 72 | PRPF4B | 0.85237790 |
| 73 | NTRK2 | 0.84985667 |
| 74 | CSNK1G2 | 0.82924713 |
| 75 | LATS1 | 0.81612913 |
| 76 | DYRK3 | 0.81270107 |
| 77 | GRK7 | 0.80704847 |
| 78 | MKNK1 | 0.78945453 |
| 79 | PBK | 0.78860527 |
| 80 | CAMK2B | 0.76744891 |
| 81 | RPS6KA4 | 0.75956559 |
| 82 | CAMKK2 | 0.75729708 |
| 83 | CAMK2D | 0.75709715 |
| 84 | PRKCQ | 0.73270508 |
| 85 | SGK3 | 0.72489487 |
| 86 | ABL2 | 0.72464112 |
| 87 | PRKAA1 | 0.72237071 |
| 88 | PKN1 | 0.71305728 |
| 89 | LIMK1 | 0.71216683 |
| 90 | PRKACG | 0.70618808 |
| 91 | MAPK15 | 0.70372400 |
| 92 | TNIK | 0.70005518 |
| 93 | CCNB1 | 0.69563994 |
| 94 | MAP3K1 | 0.69151446 |
| 95 | PRKG1 | 0.68817082 |
| 96 | PLK4 | 0.67586931 |
| 97 | JAK2 | 0.65935181 |
| 98 | PTK2B | 0.64732600 |
| 99 | EIF2AK1 | 0.63921393 |
| 100 | STK3 | 0.63302817 |
| 101 | MAP2K1 | 0.63207597 |
| 102 | SIK3 | 0.62596069 |
| 103 | RET | 0.61312120 |
| 104 | MAP3K6 | 0.61226508 |
| 105 | NEK6 | 0.61012705 |
| 106 | BRSK2 | 0.60557729 |
| 107 | MINK1 | 0.58663937 |
| 108 | DYRK1A | 0.56843735 |
| 109 | FER | 0.55748977 |
| 110 | PRKACA | 0.55227186 |
| 111 | UHMK1 | 0.54891901 |
| 112 | DYRK2 | 0.53529950 |
| 113 | ADRBK1 | 0.52169334 |
| 114 | SRPK1 | 0.51640590 |
| 115 | PTK2 | 0.51158508 |
| 116 | CAMKK1 | 0.50798081 |
| 117 | PRKCE | 0.50774641 |
| 118 | CAMK1G | 0.49851321 |
| 119 | PDK1 | 0.49054053 |
| 120 | MUSK | 0.47794389 |
| 121 | CDK5 | 0.47618202 |
| 122 | PRKCZ | 0.47331854 |
| 123 | STK38 | 0.46800011 |
| 124 | TTN | 0.46580063 |
| 125 | CSNK1G3 | 0.44426024 |
| 126 | MAP2K3 | 0.44009345 |
| 127 | CAMK4 | 0.43792752 |
| 128 | PRKCA | 0.43481559 |
| 129 | MAPK7 | 0.43272524 |
| 130 | LMTK2 | 0.42595026 |
| 131 | GRK1 | 0.42513575 |
| 132 | PRKD3 | 0.42393016 |
| 133 | STK38L | 0.42089735 |
| 134 | CSNK1D | 0.42007845 |
| 135 | NEK1 | 0.41551607 |
| 136 | MAPKAPK3 | 0.41366642 |
| 137 | RPS6KA3 | 0.40931195 |
| 138 | EPHA3 | 0.40840584 |
| 139 | CAMK1 | 0.40521497 |
| 140 | PRKACB | 0.40403920 |
| 141 | CSNK1G1 | 0.40351172 |
| 142 | CSNK1A1 | 0.38342522 |
| 143 | MAP3K5 | 0.38118744 |
| 144 | RAF1 | 0.36331008 |
| 145 | PLK3 | 0.33428551 |
| 146 | RPS6KB1 | 0.32186596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.97072807 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25296457 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.16595045 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80788489 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.75608437 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66192706 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61492764 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60378380 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56918671 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48437252 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.42735621 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.37463432 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27150891 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24478115 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.10672192 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.94277281 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.91736332 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91549472 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91483998 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.91185069 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86734231 |
| 22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.80226928 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.77257638 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.76063610 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76010404 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75841157 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73198380 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.67389710 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65739834 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.65688709 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.63035658 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.61071649 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60882770 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57540345 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56590403 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50573912 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.43655489 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.41175416 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39989573 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.39157804 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38878650 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.38710747 |
| 43 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.38271582 |
| 44 | Phototransduction_Homo sapiens_hsa04744 | 1.36307879 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34984097 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33474104 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.33237260 |
| 48 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.32270576 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 1.26091856 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.25886169 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25796714 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24517595 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23956440 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23736782 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.22857021 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 1.22681116 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21525889 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.21001439 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20311804 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18107377 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15867952 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.14327374 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.11215260 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04228845 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03550307 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01616789 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 1.01164009 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00803249 |
| 69 | Salivary secretion_Homo sapiens_hsa04970 | 1.00508247 |
| 70 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00419787 |
| 71 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00401265 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 1.00351840 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97196653 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89193812 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87251583 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87187040 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84158094 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.83864839 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81379015 |
| 80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80246309 |
| 81 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77806072 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.76876914 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73525418 |
| 84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73455606 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.70225475 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.69811533 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69111986 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68274664 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67967224 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67869759 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67609325 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.67169529 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66909739 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59880462 |
| 95 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59683087 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58567510 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.57536359 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57028410 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56320447 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55943889 |
| 101 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55730632 |
| 102 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52359706 |
| 103 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51512860 |
| 104 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.50007739 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.49053104 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48589859 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.47457005 |
| 108 | RNA degradation_Homo sapiens_hsa03018 | 0.46850886 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34784360 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.34506387 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33040632 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32493912 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29967866 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29608452 |
| 115 | Parkinsons disease_Homo sapiens_hsa05012 | 0.27370810 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26988836 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.26891201 |
| 118 | Alzheimers disease_Homo sapiens_hsa05010 | 0.25163017 |
| 119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24514528 |
| 120 | GABAergic synapse_Homo sapiens_hsa04727 | 0.23970406 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.23226920 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22104585 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.17910231 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.12370438 |
| 125 | Protein export_Homo sapiens_hsa03060 | 0.10637075 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09040045 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07900697 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.07525586 |
| 129 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.06545748 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06389245 |
| 131 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.04680346 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.02715836 |
| 133 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.02677840 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.02175663 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01836204 |
| 136 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.01135682 |
| 137 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00850549 |
| 138 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0372958 |
| 139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0295632 |
| 140 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0245710 |
| 141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0042628 |

